hims glp-1 results & Hers Data Shows Personalized Plans Drive Real Weight Loss, Few Side Effects, and Strong Adherence to Care Hims & Hers launches GLP-1

Ricci G, De Maria F, Antonini G, Turella P, Bullo A, Stella L et al

Obesity can lead to chronic, debilitating, and even life-threatening health issues such as diabetes, heart disease, and high blood pressure, so increased access to GLP-1 weight loss drugs could improve the long-term health, well-being, and outcome for millions of Americans

lengthier exhalations promote calm

Jennifer Keiser Swiss Tropical and Public Health Institute, Allschwil, Switzerland University of Basel, Basel, Switzerland Jennifer Keiser heads the Helminth Drug Development Unit at the Swiss Tropical and Public Health Institute (Swiss TPH)